Research reveals unique gut bacteria in Singaporean seniors, highlighting the microbiome's role in promoting healthier aging ...

I wrote about my experience with Mounjaro, one of the so-called “miracle” weight-loss jabs. In the days that followed, I was ...

Set to start in 2025, Relay Therapeutics is moving toward a pivotal study of experimental treatment RLY-2608 in heavily ...

The partners’ ADC didn’t significantly extend survival in lung cancer patients who were expected to benefit the most from ...

Researchers investigated the effect of microbiota therapy on the liver among patients with metabolic dysfunction-associated steatotic liver disease.

KIMMTRAK is a novel bispecific protein comprised of a soluble T cell receptor fused ... increased glucose, increased AST, increased ALT, decreased hemoglobin, and decreased phosphate. For more ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial ...

Clinical decision-making can be difficult for patients with SMA due to the lack of clinical trials comparing treatment ...

If rams are turned out in the next few weeks, we can expect lambs to begin showing up in early to mid-February. A successful ...

ALT or AST >3 times ULN (Grade ≥2 ... Proteinuria: Proteinuria was observed in 8% of CABOMETYX patients. Monitor urine protein regularly during CABOMETYX treatment. For Grade 2 or 3 proteinuria, ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...